Pink SheetJuly is inextricably linked with Independence Day in the US, but the calendar of applications that are up for Food and Drug Administration actions in July 2025 is notable for the number of novel candi
In VivoIn the top alliance by deal value, Pfizer entered into an exclusive global, ex-China, licensing agreement with 3SBio for the development, manufacturing, and commercialization of SSGJ-707, a bispecific
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On
Pink SheetChanges made to transferable exclusivity vouchers (TEVs) for antimicrobials, introduced as part of the EU pharmaceutical legislative reform package, will “weaken” their value to the point that they ar